# Nafcillin

NDC: 70860-119
Generic name: nafcillin sodium
Labeler / Manufacturer: Athenex Pharmaceutical Division, LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180815
Marketing ended: 20260630
FDA application: ANDA090005

## Active ingredients

- NAFCILLIN SODIUM: 10 g/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70860-119"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70860-119
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bc91eeb-5d8d-4058-b16a-532ba114fcd5